CANN-IL
Disease-resistant Cannabis Strains
Company Overview
Snapshot
Founded in January 2019 by Yigal Cohen, Dr. Yariv Ben-Naim, and Prof. Shlomo Margel, CANN-IL operates with 1–10 employees. The company has raised $250,000 across one funding round from Weizman Family. In June 2019, former Shin Bet Head Yaakov Peri joined CANN-IL, signaling early strategic interest in the company's direction.
Business overview
CANN-IL specializes in the identification and characterization of wild cannabis strains to detect genetic resistance against diseases. The company develops elite varieties with resistance genes suitable for various markets. Its breeding processes focus on horticultural characteristics and the quality of cannabinoids like THC and CBD, leveraging expertise from Professor Yigal Cohen’s lab at Bar-Ilan University. CANN-IL operates within the Agriculture & Food Technologies sector, specifically in Ag Tech, Farm Equipment & Treatment, Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Medical Cannabis.
Strategic signal
In June 2019, former Shin Bet Head Yaakov Peri joined CANN-IL. This appointment provided significant strategic validation and credibility to the nascent cannabis research company, suggesting a strong belief in its potential to innovate within the medical cannabis and agricultural technology sectors.
Company Intelligence Q&A
- What is CANN-IL's primary focus?
- CANN-IL specializes in identifying and characterizing wild cannabis strains to detect genetic resistance against diseases, aiming to develop elite varieties with these resistance genes for various markets.
- When was CANN-IL founded?
- CANN-IL was founded in January 2019.
- Who are the founders of CANN-IL?
- The co-founders of CANN-IL are Yigal Cohen, Dr. Yariv Ben-Naim, and Prof. Shlomo Margel.
- What was a notable early strategic development for CANN-IL?
- In June 2019, former Shin Bet Head Yaakov Peri joined CANN-IL, indicating significant interest and potential strategic guidance for the company.
- What is CANN-IL's current operational status?
- CANN-IL is currently non-active and ceased to operate in December 2022.